Eisai’s Lenvima wins nod from NICE for kidney cancer, but fight for thyroid cancer approval rages on

8th December 2017 Uncategorised 0

Japan’s Eisai, which is battling England’s drug cost watchdog to win approvals for its cancer drug lenvatinib, has finally prevailed, getting an OK for treating kidney cancer—but only after it further reduced the price.

More: Eisai’s Lenvima wins nod from NICE for kidney cancer, but fight for thyroid cancer approval rages on
Source: fierce